Prime

Type your tag names separated by a space and hit enter

The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives.

Abstract

Alterations in emotion regulation processes may form the basis of psychopathologies. The endocannabinoid (eCB) system, composed of endogenous ligands, the enzymatic machinery in charge of their metabolism and the specific metabotropic receptors, has emerged as a major neuromodulatory system critically involved in the control of emotional homeostasis and stress responsiveness. Data from animal models indicate that the eCB system plays a key role in brain development, and is probably involved in the control of emotional states from early developmental stages. The present review summarizes the latest information on the role of the eCB system in emotionality and anxiety-related disorders throughout the lifespan. Putative therapeutic strategies based on the pharmacological modulation of this system will be discussed. Given the fact that the pharmacological modulation of the eCB system has recently arisen as a promising strategy in the management of anxiety and mood disorders, the potential efficacy of this pharmacological approach (i.e. blockers of the catabolic pathway) will be discussed, as well as pharmacological alternatives such as modulators of cannabinoid receptors other than the classical CB1 receptor, or administration of other plant-derived compounds (e.g. cannabidiol).

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Department of Animal Physiology (Animal Physiology II), Faculty of Biological Sciences, Complutense University of Madrid, Madrid, Spain. emmarco@bio.ucm.es

    Source

    MeSH

    Animals
    Anxiety Disorders
    Cannabinoid Receptor Modulators
    Emotions
    Endocannabinoids
    Humans
    Mood Disorders

    Pub Type(s)

    Journal Article
    Research Support, Non-U.S. Gov't
    Review

    Language

    eng

    PubMed ID

    21693551

    Citation

    TY - JOUR T1 - The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives. AU - Marco,Eva M, AU - Laviola,Giovanni, Y1 - 2011/06/21/ PY - 2011/6/23/entrez PY - 2011/6/23/pubmed PY - 2012/8/22/medline SP - 150 EP - 63 JF - Journal of psychopharmacology (Oxford, England) JO - J. Psychopharmacol. (Oxford) VL - 26 IS - 1 N2 - Alterations in emotion regulation processes may form the basis of psychopathologies. The endocannabinoid (eCB) system, composed of endogenous ligands, the enzymatic machinery in charge of their metabolism and the specific metabotropic receptors, has emerged as a major neuromodulatory system critically involved in the control of emotional homeostasis and stress responsiveness. Data from animal models indicate that the eCB system plays a key role in brain development, and is probably involved in the control of emotional states from early developmental stages. The present review summarizes the latest information on the role of the eCB system in emotionality and anxiety-related disorders throughout the lifespan. Putative therapeutic strategies based on the pharmacological modulation of this system will be discussed. Given the fact that the pharmacological modulation of the eCB system has recently arisen as a promising strategy in the management of anxiety and mood disorders, the potential efficacy of this pharmacological approach (i.e. blockers of the catabolic pathway) will be discussed, as well as pharmacological alternatives such as modulators of cannabinoid receptors other than the classical CB1 receptor, or administration of other plant-derived compounds (e.g. cannabidiol). SN - 1461-7285 UR - https://www.unboundmedicine.com/medline/citation/21693551/abstract/The_endocannabinoid_system_in_the_regulation_of_emotions_throughout_lifespan:_a_discussion_on_therapeutic_perspectives_ L2 - http://journals.sagepub.com/doi/abs/10.1177/0269881111408459?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed ER -